Radiolabeled cetuximab%25253A dose optimization for epiderma…
Radiolabeled cetuximab%25253A dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
Article, Chapter
Full text availability for this item
Coverage:
- 1966-01-15~present; volume:1~present;issue:1~present
Coverage:
- 1996~present; volume:65~present;issue:1~present